HTA Quarterly Archive

HTA Quarterly 

Spring 2018

We examine oncology appraisal differences between NICE and SMC, market access for cell and gene therapies, and managed entry agreements.
Read issue

HTA QUarterly

Late Summer 2017

We examine medical nutrition reimbursement, severe asthma therapies, and brazil's healthcare market.
Read issue

HTA QUARTERLY

Summer 2017

We take a look at patient input into HTA decisions in 4 countries, examining new therapies for Duchenne Muscular Dystrophy, and understanding the Colombian universal healthcare model.
Read issue